This site is intended only for healthcare professionals resident in the United Kingdom

For Inflectra® (infliximab) Prescribing Information for Great Britain click here.
For Inflectra® (infliximab) Prescribing Information for Northern Ireland click here
Adverse event reporting information can be found at the bottom of the page.

PLANETAS efficacy

Inflectra /CT-P13* (infliximab) has comparable efficacy to Remicade®† in AS.1-3

ASAS20 response in adult patients with active AS1-3

Created from Park W, et al. 2013, Park W, et al. 2016, and Park W, et al. 2017.

All efficacy endpoints were comparable during long-term treatment in the maintenance and switch groups2

Explore more

Rheumtaoid arthritis safety

Learn about the safety and clinical evidence supporting the use of Inflectra in patient with heumtaoid arthritis

Learn more  

Optimising treatment

Read the guidance on optimising treatment with Inflectra and TDM and biomarkers

Find out more


*CT-P13 is marketed under different brand names including Inflectra and REMSIMA®.
†Remicade® is a registered trademark of MSD.
AS=Ankylosing spondyloarthritis; ASAS=Assessment of Spondyloarthritis International Society; CI=Confidence interval; OR=Odds ratio.
References
  1. Park W, et al. Ann Rheum Dis. 2013. 72:1605–1612.
  2. Park W, et al. Ann Rheum Dis. 2017. 76:346–354.
  3. Park W, et al. Arth Res Ther. 2016. 18:25.DOI 10.1186/s13075-016-0930-4.
PP-IFA-GBR-0519. September 2021

Quick Links

  • PLANETRA safety

  • PLANETRA efficacy

  • PLANETAS safety

  • PLANETAS efficacy

  • NOR-SWITCH safety

  • NOR-SWITCH effiacy

Learn about the evidence supporting the use of Inflectra in patients with Crohn’s disease. 

Find out more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No